Xiaofeng Zheng

16PUBLICATIONS
32CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 11, 2026
Targeting SMC3 deacetylation synergizes with XPO1 inhibition to reprogram the epigenetic landscape and suppress NPM1-mutated acute myeloid leukemia.

|Oct 04, 2025
K11- and K29-ubiquitination-mediated nuclear translocation of glycolytic enzyme aldolase A promotes pancreatic cancer progression by NF-κB activation.

Siru Zhou, Yulin Li, Chao Wang

|Sep 10, 2024
CD98hc promotes drug resistance in extranodal natural killer/T cell lymphoma through tumor cell-derived small extracellular vesicles.

Liming Liao, Ping Yang, Weilong Zhang

|Jun 28, 2023
ATM-ESCO2-SMC3 axis promotes 53BP1 recruitment in response to DNA damage and safeguards genome integrity by stabilizing cohesin complex.

Jianfeng Fu, Siru Zhou, Huilin Xu

|Jun 23, 2023
SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer.

Min Wei, Xinping Huang, Liming Liao

|Mar 07, 2023
hCINAP alleviates senescence by regulating MDM2 via p14ARF and the HDAC1/CoREST complex.

Xinping Huang, Yan Zhao, Min Wei

Pageof 3

Frequent Collaborators

3 joint publications

Yonglu Tian

3 joint publications

Liming Liao

2 joint publications

Ruidan Xu

2 joint publications

Xinping Huang